Skip to content
drillr.ai
Sign up

GLTO

Galecto, Inc.

NASDAQ · Healthcare · Biotechnology · US

$21.58
−3.36%
Ask drillr

Income statement

MetricTTM2025202420232022
Revenue
Total Revenue—————
Cost of Revenue68.0K34.0K———
Gross Profit(68.0K)(34.0K)———
Operating Expenses
R&D Expense224.3M201.2M10.8M23.8M48.2M
SG&A Expense14.8M9.7M10.5M12.7M13.0M
General & Admin Expense14.8M9.7M10.5M12.7M13.0M
Selling & Marketing Expense—————
Other Expenses(68.0K)—968.0K3.4M—
Total Operating Expenses239.0M210.9M22.3M39.9M61.2M
Cost and Expenses239.1M210.9M22.3M39.9M61.2M
Operating Income (EBIT)(239.1M)(210.9M)(22.3M)(39.9M)(61.2M)
Non-Operating
Interest Income4.2M1.2M844.0K1.7M722.0K
Interest Expense————417.0K
Net Interest Income4.2M1.2M844.0K1.7M305.0K
Other Non-Op Income/Expense4.1M1.1M862.0K1.6M(417.0K)
Non-Operating Income (excl Interest)(4.1M)(1.1M)(968.0K)(3.4M)—
EBT (Pre-Tax Income)(235.0M)(209.8M)(21.4M)(38.3M)(61.6M)
Income Tax Expense90.0K50.0K41.0K——
Bottom Line
Net Income(235.1M)(209.8M)(21.4M)(38.3M)(61.6M)
Earnings from Cont. Ops(235.1M)(209.8M)(21.4M)(38.3M)(61.6M)
Earnings from Discont. Ops—————
Bottom Line Net Income(235.1M)(5.4M)(21.4M)(38.3M)(61.6M)
Per Share
Basic EPS($20.04)($3.71)($18.53)($36.08)($61.04)
Diluted EPS($20.04)($3.71)($18.53)($36.08)($61.04)
Revenue Per Share$0.00$0.00$0.00$0.00$0.00
Shares
Basic Shares Outstanding1.6M1.5M1.2M1.1M1.0M
Diluted Shares Outstanding1.6M1.5M1.2M1.1M1.0M
Profitability Metrics
EBITDA(234.9M)(209.8M)(21.1M)(35.6M)(60.7M)
D&A94.0K34.0K181.0K830.0K490.0K
EBIT(235.0M)(209.8M)(21.3M)(36.5M)(61.2M)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026